Company: INDP
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001641172-25-005234
Chunk: 1

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 1
---
 provided to building security. As such, in order to facilitate your attendance at the Annual Meeting, we strongly encourage you to advise Nir Sassi by email at nir@indaptusrx.comor phone at (646) 427-2727 if you plan to attend the meeting prior to 5:00 p.m., Eastern time, on June 9, 2025, so that we can timely provide your name to building security.

The Notice of Meeting and Proxy Statement on the following pages describe the matters to be presented at the Annual Meeting. Please see the section called “Who can attend the Annual Meeting?” on page 4 of the proxy statement for more information about how to attend the meeting in person.

Whether or not you attend the Annual Meeting, it is important that your shares be represented and voted at the Annual Meeting. Therefore, I urge you to promptly vote and submit your proxy by phone, via the Internet, or, if you received paper copies of these materials, by signing, dating and returning the enclosed proxy card in the enclosed envelope, which requires no postage if mailed in the United States. If you have previously received our Notice of Internet Availability of Proxy Materials, then instructions regarding how you can vote are contained in that notice. If you have received a proxy card, then instructions regarding how you can vote are contained on the proxy card. If you decide to attend the Annual Meeting, you will be able to vote in person, even if you have previously submitted your proxy.

Thank you for your support.

Sincerely,

| /s/                          |
| Roger                        
 J. Pomerantz, M.D., F.A.C.P. |
| Chairman                     |

<div align='center'>Table of Contents</div>

| NOTICE OF ANNUAL MEETING OF STOCKHOLDERS                            |  1 |
| PROXY STATEMENT                                                     |  2 |
| QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING OF STOCKHOLDERS |  4 |
| PROPOSALS TO BE VOTED ON                                            |  7 |
| REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS             | 21 |
| EXECUTIVE OFFICERS                                                  | 21 |
| CORPORATE GOVERNANCE                                                | 21 |
| COMMITTEES OF THE BOARD                                             | 24 |
| EXECUTIVE COMPENSATION                                              | 27 |
| DIRECTOR COMPENSATION                                               | 39 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT